| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |